ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2049

Nasal Bacteria Associated with Disease Activity and ANCA Levels in Granulomatosis with Polyangiitis

Rennie Rhee1, Jiarui Lu1, Kyle Bittinger2, Antoine Sreih1, Jung-Jin Lee3, Lisa Mattei3, Brendan Kelly4, Peter C. Grayson5, Hongzhe Lee4, Ronald Collman4 and Peter Merkel1, 1University of Pennsylvania, Philadelphia, PA, 2Children's Hospital of Philadelphia, Philadelphia, PA, 3Children's Hospital of Philadelphia, Philadelphia, 4University of Pennsylvania, Philadelphia, 5Systemic Autoimmunity Branch, National Institutes of Health, NIAMS, Bethesda, MD

Meeting: ACR Convergence 2020

Keywords: ANCA, Disease Activity, Granulomatosis with Polyangiitis (GPA), microbiome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2020

Title: Vasculitis – ANCA-Associated (2048–2052)

Session Type: Abstract Session

Session Time: 11:00AM-11:50AM

Background/Purpose: Nasal bacteria have been linked to disease activity in granulomatosis with polyangiitis (GPA) with most studies focused on Staphylococcus aureus. Our previous study identified dynamic changes in the ratio of nasal Corynebacterium to Staphylococcus (at the genus level) prior to and during a relapse. Corynebacteria are a common commensal that inhabits the skin and nose and is known to directly interact with S. aureus. The objective of this study was to evaluate species-level identity of nasal bacteria and their association with disease activity and ANCA levels in GPA.

Methods: Nasal bacterial composition was examined using 16S rRNA gene sequencing of nasal swabs of 19 patients with GPA followed longitudinally approximately every 3 months (N = 76 visits, median time between visits 4 months). Nine patients had at least 1 visit with active disease and 10 patients remained in remission during follow-up. Disease activity was determined by BVAS/WG. Only PR3-ANCA results obtained by ELISA at the study site were included for ANCA analyses (11 patients with 29 visits). We evaluated the relative abundance of the 10 most abundant bacterial species across all visits as well as the ratios between these 10 species. Generalized estimating equations evaluated the association between bacteria and i) visit type (stable remission [n=41], pre-pre-relapse [n=4], pre-relapse [n=10], relapse [n=10], post-relapse [n=9]), and ii) ANCA levels, accounting for repeated measures within an individual. Test for trend examined linear trends in bacterial abundance across visit types. Models were adjusted for use of antibiotics, immunosuppressive medications, nasal irrigation, and, when analyzing Corynebacteria, presence of S. aureus.

Results: Corynebacterium tuberculostearicum featured prominently in our analyses. Specifically, we found the abundance of C. tuberculostearicum significantly increased across visit types in GPA when evaluating any relapse (adjusted P = 0.04; Figure 1) and relapse involving the sinonasal area (adjusted P < 0.01). The presence of S. aureus (32/76 visits [42%]) was independently associated with a higher C. tuberculostearicum abundance (adjusted P = 0.02). C. tuberculostearicum abundance was associated with higher levels of PR3-ANCA (adjusted P = 0.02; Figure 2). Analysis of bacterial ratios identified significantly increasing ratios of C. tuberculostearicum to S. caprae abundance and C. pseudodiphtheriticum to S. caprae abundance across visit types (both adjusted P < 0.01; Figure 3).

Conclusion: Our species-level analysis has uncovered a novel finding between C. tuberculostearicum and both disease relapse and ANCA levels in GPA. Our results also detected associations between C. tuberculostearicum and Staphylococcus species, including S. aureus. Prior studies demonstrated a pathogenic role for C. tuberculostearicum in chronic rhinosinusitis and direct interactions between Corynebacterium spp. and S. aureus. We propose that competitive interactions between Corynebacteria and Staphylococci induce nasal mucosal immune responses which, in susceptible hosts predisposed to autoimmunity and ANCA formation, lead to systemic relapse in GPA.

Figure 1. Increasing abundance of nasal Corynebacterium tuberculostearicum is associated with relapse in granulomatosis with polyangiitis (GPA). Longitudinal study visits categorized by visit type: stable remission (n=41), pre-pre-relapse remission (n=4), pre-relapse remission (n=10), relapse (n=12), and post-relapse remission (n=9). Test for trend detected a significant linear increase in nasal C. tuberculostearicum abundance across visits even after adjusting for antibiotics, immunosuppressives, nasal irrigation, and presence of S. aureus (adjusted P = 0.04). Similar results found when analyzing only relapses involving sinonasal area.

Figure 2. Relative abundance of nasal Corynebacterium tuberculostearicum is associated with PR3-ANCA level in granulomatosis with polyangiitis (GPA). Scatterplot demonstrates association between abundance of nasal C. tuberculostearicum and serum PR3-ANCA levels in 11 patients with total of 29 visits (unadjusted P < 0.01). Association remained significant even after adjusting for use of antibiotics, immunosuppressives, and nasal irrigation (adjusted P = 0.02). Reference range for normal PR3-ANCA < 20 units.

Figure 3. Ratio of bacteria associated with relapse in granulomatosis with polyangiitis (GPA). Ratio of bacterial abundance were log-transformed and test for trend evaluated for changes across visit types. An increasing ratio of Corynebacterium tuberculostearicum to Staphylococcus caprae and C. pseudodiphtheriticum to S. caprae were both associated with visit type, even after adjusting for antibiotics, immunosuppressives, and nasal irrigation (both adjusted P < 0.01).


Disclosure: R. Rhee, None; J. Lu, None; K. Bittinger, None; A. Sreih, Bristol-Myers Squibb, 3, Alexion, 1; J. Lee, None; L. Mattei, None; B. Kelly, None; P. Grayson, None; H. Lee, None; R. Collman, None; P. Merkel, AbbVie, 5, Biogen, 5, Celgene, 2, 5, ChemoCentryx, 2, 5, CSL Behring, 5, Forbius, 2, 5, Genentech/Roche, 2, 5, Genzyme/Sanofi, 2, 5, GlaxoSmithKline, 2, 5, InflaRx, 2, 5, Insmed, 5, Jannsen, 5, Kiniksa, 5, Magenta, 5, Novartis, 5, Pfizer, 5, Sparrow, 5, Talaris, 5, AstraZeneca, 2, 5, Boeringher-Ingelheim, 2, 5, Bristol-Myers Squibb, 2, 5, UpToDate, 7.

To cite this abstract in AMA style:

Rhee R, Lu J, Bittinger K, Sreih A, Lee J, Mattei L, Kelly B, Grayson P, Lee H, Collman R, Merkel P. Nasal Bacteria Associated with Disease Activity and ANCA Levels in Granulomatosis with Polyangiitis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/nasal-bacteria-associated-with-disease-activity-and-anca-levels-in-granulomatosis-with-polyangiitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/nasal-bacteria-associated-with-disease-activity-and-anca-levels-in-granulomatosis-with-polyangiitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology